Meet the 2018 Rock Docs

See past Rock Docs »

Milan Chheda, MD
Assistant Professor of Medicine, Medical Oncologist, Neuro-Oncologist, Siteman Cancer Center

Dr. Milan Chheda is an Assistant Professor of Medicine and Neurology at Washington University School of Medicine. Dr. Chheda and his research team are re-envisioning the way we treat patients with brain tumors. Most recently, he has received national attention for his work, in collaboration with Michael Diamond and Jeremy Rich, using the Zika virus to target and kill brain cancer stem cells. His innovative and cutting-edge research is well positioned to have a significant impact in both identifying the genetic causes of brain tumors and developing personalized treatment options that could allow brain tumor patients to live fuller and longer lives.

Mackenzie Daly, MD
Assistant Professor, Radiation Oncologist, Siteman Cancer Center

Dr. Mackenzie Daly is an Assistant Professor of Radiation Oncology. Dr. Daly joined Washington University in 2014 to become the Medical Director of Radiation Oncology at Christian Hospital Northeast. She is a member of the Siteman multidisciplinary head and neck team and her practice focuses on treating cancers of the head and neck. Dr. Daly's passion is to raise the standard of care in the St. Louis area by improving patient access to quality cancer care and expanding opportunities to participate in clinical trials.

 

Roberta Faccio, PhD
Professor of Orthopedic Surgery, Siteman Cancer Center

Dr. Roberta Faccio is a Professor of Orthopedic Surgery at Washington University School of Medicine. Her research interests involve understanding the communication between a primary tumor with the bone microenvironment. Using genetic and pharmacological approaches, her goal is to dissect the signaling pathways leading to immune suppression and activation of bone cells during breast cancer progression.

 

 

Todd Fehniger, MD, PhD
Associate Professor of Medicine, Division of Oncology, Sections of Stem Cell Biology and Bone Marrow Transplantation

Dr. Fehniger is an Associate Professor of Medicine in the Division of Oncology and Section of Bone Marrow Transplantation and Leukemia at Siteman Cancer Center. Fehniger's clinical expertise is in lymphoma, cellular therapy, and bone marrow transplantation. The long-term goals of his laboratory are to better understand the molecular programs that regulate natural killer (NK) cell development and activation and translate basic NK cell biology into novel treatments for patients with cancer. His clinical interests are lymphoma, cellular therapy and hematopoietic stem-cell transplantation.

 

Katherine Glover-Collins, MD, PhD
Assistant Professor Surgery, Division of General Surgery, Section of Endocrine and Oncologic Surgery, Siteman Cancer Center

Dr. Katherine Glover-Collins is an Assistant Professor in the Section of Endocrine and Oncologic Surgery after completing a breast surgical oncology fellowship at Washington University School of Medicine. Glover-Collins specializes in breast oncology, breast biopsy, and benign diseases of the breast, family history of breast cancer, breast reconstruction liaison, and disparities in breast cancer treatment.

 

 

Angela Hirbe, MD, PhD
Assistant Professor of Medicine, Division of Oncology, Section of Medical Oncology

Dr. Angela Hirbe is an Assistant Professor of Medicine in the Division of Oncology at the Washington University School of Medicine. Dr. Hirbe's clinical expertise is in sarcomas and rare tumors. Her research interest focuses on understanding the genetic causes of malignant peripheral nerve sheath tumors (MPNSTs), an aggressive soft tissue sarcoma that occurs at an increased frequency in patients with Neurofibromatosis Type 1 (NF1) tumor predisposition syndrome.

 

 

Jason Weber, PhD
Professor of Medicine, Division of Oncology, Section of Molecular Oncology

Dr. Jason Weber is a professor at Washington University as well as involved with the Department of Medicine Oncology and the Department of Cell Biology and Physiology at BJC Institute of Health. His research interests involve cell cycle, tumor suppressors and oncogenes. His goal is to understand how cells regulate their growth rate and to relate these processes to their growing knowledge of human cancer progression.